Global access to commercial CAR T-cell therapies: a cross-sectional study of health technology assessment across the G20 countries
- DOI
- 10.1182/blood.2025030872
- Published
- 2026-04-02
- Container
- Blood
- Publisher
- American Society of Hematology
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1182/blood.2025030872,
title = {Global access to commercial CAR T-cell therapies: a cross-sectional study of health technology assessment across the G20 countries},
author = {Alex Y. Ge and William B. Feldman and Martin F. Kaiser and Kai Rejeski and Gloria Iacoboni and Gaurav Narula and Jason Yongsheng Chan and Michael J. Dickinson and Aaron S. Kesselheim and Edward R. Scheffer Cliff},
year = {2026},
journal = {Blood},
doi = {10.1182/blood.2025030872},
url = {https://doi.org/10.1182/blood.2025030872}
}RIS
TY - JOUR TI - Global access to commercial CAR T-cell therapies: a cross-sectional study of health technology assessment across the G20 countries AU - Alex Y. Ge AU - William B. Feldman AU - Martin F. Kaiser AU - Kai Rejeski AU - Gloria Iacoboni AU - Gaurav Narula AU - Jason Yongsheng Chan AU - Michael J. Dickinson AU - Aaron S. Kesselheim AU - Edward R. Scheffer Cliff PY - 2026 JO - Blood DO - 10.1182/blood.2025030872 UR - https://doi.org/10.1182/blood.2025030872 ER -
APA
Ge, A. Y., Feldman, W. B., Kaiser, M. F., Rejeski, K., Iacoboni, G., Narula, G., Chan, J. Y., Dickinson, M. J., Kesselheim, A. S., & Cliff, E. R. S. (2026). Global access to commercial CAR T-cell therapies: a cross-sectional study of health technology assessment across the G20 countries. Blood. https://doi.org/10.1182/blood.2025030872
Source records
- crossref · retrieved 2026-09-26T15:18:49.179Z